The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank

BACKGROUND: Chronic kidney disease (CKD) and non-alcoholic fatty liver disease (NAFLD) frequently co-exist. We assess the impact of having NAFLD on adverse clinical outcomes and all-cause mortality for people with CKD. METHODS: A total of 18,073 UK Biobank participants identified to have CKD (eGFR &...

Descripción completa

Detalles Bibliográficos
Autores principales: Hydes, Theresa J., Kennedy, Oliver J., Buchanan, Ryan, Cuthbertson, Daniel J., Parkes, Julie, Fraser, Simon D. S., Roderick, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193672/
https://www.ncbi.nlm.nih.gov/pubmed/37198624
http://dx.doi.org/10.1186/s12916-023-02891-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193672/
https://www.ncbi.nlm.nih.gov/pubmed/37198624
http://dx.doi.org/10.1186/s12916-023-02891-x

Ejemplares similares